16 September 2026 editorial review · Trial
Qualitative meal-size estimation vs carb counting in AID: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the trial evidence page →Baseline trial evidence review: M–S
Outcome: Replaced vague eligibility with substantive registry age, diagnosis, treatment and key biomarker restrictions; no efficacy inferred.
Registry: NCT06687434. Endpoint reviewed: Percentage of time in target range (70-18mg/dl) (Screening, after 4-6 weeks, after 3 months and after 6 months); Hemoglobin A1C (Screening, after 4-6 weeks, after 3 months and after 6 months); Percentage Continuous glucose monitoting usage (Screening, after 4-6 weeks, after 3 months and after 6 months); Number of Episodes of severe hypoglycemia (Screening, after 4-6 weeks, after 3 months and after 6 months); Number of episodes of Diabetic Ketoacidosis (Screening, after 4-6 weeks, after 3 months and after 6 months). Eligibility reviewed: Age 6 Years to 18 Years; diagnosis/stage, prior therapy and key biomarker criteria compared with site summary. Full exclusions remain in the registry. Literature access limit: No usable primary abstract was independently recovered for this record in this pass. Current registry protocol was the main source; detailed sponsor or conference data remain dependent on the cited source and were not fully reverified.